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INTRODUCTION:  Primary  central  nervous  lymphoma(PCNSL)  is a rare  form  of non-Hodgkin  lymphoma
conﬁned  to the  central  nervous  system.  Most  of  the  lesions  are  supratentorial  and periventricular,  often
involving  deep  structures  such  as  corpus  callosum  and  basal  ganglion.  Isolated  intraventricular  lymphoma
is rare and  only  a  few  case  reports.  We  report,  to the  best  of our  knowledge,  the  seventh  case  of  isolated
PCNSL  in the  fourth  ventricle  in  an  immunocompetent  patient.
PRESENTATION  OF  CASE:  A 61-year-old  male  presenting  with  3 months  of  headache  and  dizziness  followed
with unsteady  gait  for days.  The  MR imaging  of brain  revealed  a  homogeneously  enhancing  lesion  occu-
pying  almost  the  whole  4th ventricle.The  tumor  was removed  subtotally  via  suboccipital  craniotomy.
Histopathology  revealed  the  lesion  be  a diffuse  large  B-cell  lymphoma.
DISCUSSION:  PCNSL  is an  important  consideration  in the  differential  diagnosis  of  intracranial  mass lesion.
The unusual  location  in surgically  accessible  fourth  ventricle  in  posterior  fossa,  the  isolation  of  the tumor
may  present  a compelling  indication  for surgical  resection.
CONCLUSION:  We  suggest  that primary  lymphoma  should  be  considered  with  homogenous  lesions  of the
4th ventricle.  Also  aggressive  surgical  resection  in this  surgically  accessible  location,  instead  of biopsy
only,  is  rational.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Primary central nervous lymphoma (PCNSL) is a rare form of
non-Hodgkin lymphoma accounting for 1–4% of all brain neo-
plasms [1–6]. It is usually associated with immunodeﬁciency(most
commonly HIV) but is increasingly observed in immunocompe-
tent patients with no known etiology or risk factors [4]. Therefore,
it is an important consideration in the differential diagnosis of
intracranial mass lesion. PCNSL almost always presents as a cere-
bral parenchyma lesion whereas secondary CNS lymphoma tends
to present as leptomeningeal metastasis [7]. Isolated intraventric-
ular lymphoma is rare. Herein, we report a case of primary isolated
lymphoma of the fourth ventricle in an immunocompetent patient.
2. Presentation of case
A 61-year-old man  presented with a 3-month history of
headache, dizziness and progressively unsteady gait. He also had
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medical history of hypertension and diabetes mellitus under regu-
lar control.
On examination, he was  found to have mild cerebellar ataxia.
Magnetic resonance imaging (MRI) of his brain showed a homo-
geneously enhancing, well deﬁned mass lesion occupying almost
the entire fourth ventricle (Fig. 1). The mass lesion was  homo-
geneously enhanced and lack of necrosis or hemorrhage. Neither
cystic appearance nor calciﬁcations was  found. The radiologist’s
impression was  that of a lymphoma or ependymoma. Initial blood
testing was  unremarkable. An additional work-up with HIV testing
and computed tomography (CT) scans of the neck, chest, abdomen,
and pelvis showed negative results.
We performed a suboccipital craniotomy and the tumor
was accessed through a transvermian approach. The tumor was
exophytic,grayish in color, soft and slightly vascularized. Clear
tumor- brainstem interface but invasion of left vermis was
noted intraoperatively. Complete resection of the intraventric-
ular lesion was achieved. The frozen section showed tumor
cells of unknown origin. The permanent section showed dif-
fuse inﬁltration of a typical lymphocytes with irregular nuclei.
Immunohistochemistry stains showed that the cells were positive
for CD20 and CD10. The morphology and immunohistochem-
istry proﬁle were consistent with a diffuse large B-cell lymphoma
(Fig. 2).
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Fig. 1. T1-weighted, gadolinium-enhanced sagittal magnetic resonance image (left) and axial MRI  (right), showing a well-demarcated intensely enhancing lesion occupied
almost the entire fourth ventricle.
Fig. 2. The Hematoxylin-eosin stain revealed diffuse inﬁltration of atypical lymphocytes with irregular nuclei (a). Immunohistochemistry stains show the cells positive for
CD20  (b) and CD10 (c).
The patient has a smooth postoperative course without neuro-
logical deﬁcit and his headache and gait disturbance had markedly
improved.
The patient was commenced on 6 cycles of chemotherapy with
Rituximab and Methotrexate. The patient remains well at three
months from diagnosis.
3. Discussion
PCNSL is a rare tumor, and only a few case reports have
addressed PCNSL in fourth ventricule [2–6,8]. Since the brain is
an immunologically privileged site which does not contain lym-
phatics or lymphoid tissue. The origin of such a primary tumor
is unclear. Hochberg et al. [9] suggested that the clone of malig-
nant systemic lymphocytes which displaying speciﬁc adhesion
molecules and bind to the speciﬁc proteins only presented in the
CNS might be pathogenesis. Signiﬁcant risk factor is acquired or
congenital immunodeﬁciency [6]. However, It has increased inci-
dence in immunocompetent patients over the past few decades.
This increase is independent of advances in neuroimaging or the
general aging of the population [10]. Therefore, it is an impor-
tant consideration in the differential diagnosis of intracranial mass
lesions.
Despite the image diagnosis of PCNSL is challenging, there are
several key imaging characteristics of CNS lymphoma. PCNSL typi-
cally shows intermediate to low signal intensity on T1-weighted
images and a isointense or hyperintense signal on T2-weighted
images. Contrast uptake is usually avid and homogenous. Because
of its high cellularity, it tends to be hyperintense on a diffuse
weighed image and hypointense on apparent diffusion coefﬁcient
images. MR spectroscopy may  show a high choline-to-creatine ratio
[11]. The diagnosis of lymphoma in our case serves to reinforce
the previous reports-to include it in the differential diagnosis of an
homogenously enhanced lesion in the fourth ventricle.
Given the good responsiveness of CNS lymphoma to chemoradi-
ation, the PCNSL are considered non-surgical tumors and attempt
to resection or decompression has been shown of no beneﬁt due
to its diffuse inﬁltration and often deep seated locations [12]. The
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surgical consensus is minimally invasive biopsy for tissue diagno-
sis. However, survival outcomes mentioned for PCNSL have been
uniformly disappointing despite recent advanced and the often ini-
tial dramatic response to chemoradiation. Recent investigators are
challenging this conservative surgical manner [13,14]. The German
Primary CNS Lymphoma Study Group 1 (G-PCNSL-SG-1) found that
the overall survival and progression-free-survival were signiﬁcant
shorter in the biopsied group compared with subtotal and total
resection group [13]. There are also reports suggested that surgical
debulking may  provide not only signiﬁcant clinical beneﬁt but also
elimination the cell populations with drug resistance potential. It
is also correlated with better progression-free survival and overall
survival [14]. In addition, the unusual location in surgically acces-
sible fourth ventricle in posterior fossa, the isolation of the tumor
may  present a compelling indication for surgical resection [15]. It
can provide the possibility for the patient to be shunt independent
and also prevent from intraabdominal tumor seeding.
4. Conclusion
We  suggest that PCNSL should be considered with homogenous
lesions of the fourth ventricle. Also aggressive surgical resection in
this surgically accessible location, instead of biopsy only, is rational.
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